U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143318) titled 'First-in-Human Single and Multiple Dose of KLA578-1 for Injection' on July 23.
Brief Summary: The purpose of this study is to evaluate the safety and tolerability and pharmacokinetics of single and multiple doses of KLA578-1 for injection in healthy volunteers
Study Start Date: June 05
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: KLA578-1 for injection
Intravenous injection, single dose
DRUG: Etopcoxib Tablets
P.O., single dose
Recruitment Status: RECRUITING
Sponsor: Sichuan Kelun Pharmaceutical Co., Ltd
Disclaimer: Curated by HT Syndication....